PeptiDream Inc. (4587.T)

JPY 2603.5

(-0.53%)

Total Liabilities Summary of PeptiDream Inc.

  • PeptiDream Inc.'s latest annual total liabilities in 2023 was 29.11 Billion JPY , down -8.51% from previous year.
  • PeptiDream Inc.'s latest quarterly total liabilities in 2024 Q2 was 37.11 Billion JPY , up 25.4% from previous quarter.
  • PeptiDream Inc. reported annual total liabilities of 31.82 Billion JPY in 2022, up 1863.73% from previous year.
  • PeptiDream Inc. reported annual total liabilities of 1.62 Billion JPY in 2021, down -67.91% from previous year.
  • PeptiDream Inc. reported quarterly total liabilities of 29.59 Billion JPY for 2024 Q1, up 1.65% from previous quarter.
  • PeptiDream Inc. reported quarterly total liabilities of 26.68 Billion JPY for 2023 Q2, down -4.58% from previous quarter.

Annual Total Liabilities Chart of PeptiDream Inc. (2023 - 2011)

Historical Annual Total Liabilities of PeptiDream Inc. (2023 - 2011)

Year Total Liabilities Total Liabilities Growth
2023 29.11 Billion JPY -8.51%
2022 31.82 Billion JPY 1863.73%
2021 1.62 Billion JPY -67.91%
2020 5.04 Billion JPY 501.84%
2019 839.05 Million JPY -67.62%
2018 2.59 Billion JPY 44.47%
2017 1.79 Billion JPY 23.89%
2016 1.44 Billion JPY -15.52%
2015 1.71 Billion JPY 107.46%
2014 826.01 Million JPY 507.05%
2013 136.07 Million JPY -40.82%
2012 229.91 Million JPY 192.55%
2011 78.59 Million JPY 0.0%

Peer Total Liabilities Comparison of PeptiDream Inc.

Name Total Liabilities Total Liabilities Difference
KOHJIN BIO CO LTD 3.24 Billion JPY -796.672%
PRISM BioLab Co.,LTD 63.41 Million JPY -45813.641%
GNI Group Ltd. 26.34 Billion JPY -10.526%
Linical Co., Ltd. 10.3 Billion JPY -182.529%
Trans Genic Inc. 3.81 Billion JPY -663.647%
MEDINET Co., Ltd. 590.2 Million JPY -4832.921%
Soiken Holdings Inc. 697.02 Million JPY -4076.95%
Cytori Cell Research Institute, Inc. 3.02 Billion JPY -863.811%
AnGes, Inc. 2.78 Billion JPY -943.759%
OncoTherapy Science, Inc. 513.6 Million JPY -5568.595%
Nxera Pharma Co., Ltd. 90.38 Billion JPY 67.79%
Immuno-Biological Laboratories Co., Ltd. 353.27 Million JPY -8141.35%
NanoCarrier Co., Ltd. 1.64 Billion JPY -1664.621%
Carna Biosciences, Inc. 472.35 Million JPY -6063.648%
CanBas Co., Ltd. 91.98 Million JPY -31550.105%
D. Western Therapeutics Institute, Inc. 1.09 Billion JPY -2562.229%
RaQualia Pharma Inc. 809.83 Million JPY -3495.112%
Chiome Bioscience Inc. 593.73 Million JPY -4803.618%
Kidswell Bio Corporation 4.25 Billion JPY -584.386%
Oncolys BioPharma Inc. 566.5 Million JPY -5039.329%
Ribomic Inc. 155.8 Million JPY -18585.89%
SanBio Company Limited 2.25 Billion JPY -1191.162%
Healios K.K. 11.28 Billion JPY -157.968%
BrightPath Biotherapeutics Co., Ltd. 251.26 Million JPY -11486.904%
Kubota Pharmaceutical Holdings Co., Ltd. 369 Million JPY -7790.054%
Delta-Fly Pharma, Inc. 241.49 Million JPY -11955.76%
StemRIM 187 Million JPY -15469.144%
CellSource Co., Ltd. 677.73 Million JPY -4195.798%
FunPep Company Limited 189.32 Million JPY -15278.029%
Kringle Pharma, Inc. 596.95 Million JPY -4777.135%
Stella Pharma Corporation 1.44 Billion JPY -1916.77%
TMS Co., Ltd. 97.68 Million JPY -29703.047%
Noile-Immune Biotech Inc. 91.49 Million JPY -31720.993%
Cuorips Inc. 200.96 Million JPY -14387.537%
K Pharma,Inc. 209.13 Million JPY -13821.361%
Takara Bio Inc. 11.42 Billion JPY -154.941%
ReproCELL Incorporated 741.03 Million JPY -3828.886%
PhoenixBio Co., Ltd. 917.71 Million JPY -3072.484%
StemCell Institute Inc. 3.85 Billion JPY -656.125%
Japan Tissue Engineering Co., Ltd. 908.43 Million JPY -3104.899%
CellSeed Inc. 301.04 Million JPY -9571.014%